Mar 30, 2026 09:01AM
Mar 30, 2026 09:00AM
Mar 18, 2026 09:00AM
Dec 16, 2025 08:30AM
Nov 3, 2025 09:00AM
Oct 13, 2025 09:00AM
Sep 18, 2025 10:00AM Roche achieves first CLIA 'Moderate Complexity' categorization for Ionify® 25-Hydroxy Vitamin D total test
Aug 4, 2025 08:00AM
Jul 24, 2025 09:00AM
Jan 13, 2025 01:00AM
Jan 9, 2025 01:00AM
Nov 25, 2024 01:00AM
Nov 5, 2024 09:15AM
Oct 18, 2024 02:13PM Roche receives FDA approval for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY
Oct 8, 2024 01:00AM
Jun 18, 2024 01:00AM
Apr 10, 2024 01:00AM
Dec 9, 2023 11:30AM
Nov 20, 2023 01:00AM
Sep 6, 2023 01:00AM
Jun 27, 2023 09:03AM Roche receives FDA clearance for additional Alzheimer's disease Cerebrospinal Fluid (CSF) assays, supporting timely diagnosis and treatment decision-making
Mar 6, 2023 01:00AM
Dec 11, 2022 01:02AM
Nov 14, 2022 08:33PM
Nov 10, 2022 08:05AM
Nov 3, 2022 09:00AM
Sep 19, 2022 01:43PM
Sep 19, 2022 01:40PM Roche granted FDA clearance for cobas pure integrated solutions for low- to mid-volume laboratories
Aug 11, 2022 01:00AM
Jul 22, 2022 07:03AM
Jul 11, 2022 05:45AM
Dec 17, 2021 08:00AM
Dec 13, 2021 01:00AM
Nov 23, 2021 09:15AM
Oct 18, 2021 01:00AM Roche announces collaboration with Ibex Medical Analytics to develop artificial intelligence-based digital pathology applications for improved patient care
Jul 19, 2021 01:00AM
Jun 18, 2021 11:42AM
Jun 18, 2021 11:30AM
May 18, 2021 01:00AM
Mar 9, 2021 01:00AM
Feb 11, 2021 10:02AM
Feb 11, 2021 10:00AM Roche receives first FDA clearance for urine sample type for BK virus quantitative test to aid in the improvement of care for transplant patients
Feb 8, 2021 12:00PM
Feb 8, 2021 12:00PM
Dec 1, 2020 11:30AM
Oct 29, 2020 12:45PM
Sep 18, 2020 01:00AM
Aug 17, 2020 02:00AM
Jul 29, 2020 01:00AM Genentech Provides an Update on the Phase III COVACTA Trial of Actemra in Hospitalized Patients With Severe COVID-19 Associated Pneumonia
Jul 13, 2020 01:03AM

322,899 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All